Search - Université de Rennes Access content directly

Filter your results

23 Results
Structure: Internal structure identifier : 463769
Image document

Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study.

Mira Tout , Olivier Casasnovas , Michel Meignan , Thierry Lamy , Franck Morschhauser et al.
Blood, 2017, 129 (19), pp.2616-2623. ⟨10.1182/blood-2016-10-744292⟩
Journal articles hal-01547802v1

Salvage therapy post pomalidomide-based regimen in relapsed/refractory myeloma

Guillemette Fouquet , Lionel Karlin , Margaret Macro , Denis Caillot , Murielle Roussel et al.
Annals of Hematology, 2018, 97 (5), pp.831-837. ⟨10.1007/s00277-018-3236-6⟩
Journal articles hal-01728968v1

Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma

Steven Le Gouill , Catherine Thieblemont , Lucie Oberic , Anne Moreau , Krimo Bouabdallah et al.
New England Journal of Medicine, 2017, 377 (13), pp.1250-1260. ⟨10.1056/NEJMoa1701769⟩
Journal articles hal-02329536v1

Addition of lomustine to idarubicin and cytarabine improves the outcome of elderly patients with de novo acute myeloid leukemia: a report from the GOELAMS.

Arnaud Pigneux , Jean-Luc Harousseau , Francis Witz , Mathieu Sauvezie , Marie-Christine Bene et al.
Journal of Clinical Oncology, 2010, 28 (18), pp.3028-34. ⟨10.1200/JCO.2009.26.4648⟩
Journal articles hal-00849638v1
Image document

Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma

Maroulio Pertesi , Maxime Vallée , Xiaomu Wei , Maria Revuelta , Perrine Galia et al.
Leukemia, 2019, 33 (9), pp.2324-2330. ⟨10.1038/s41375-019-0452-6⟩
Journal articles hal-02190723v1

Evolving characteristics and outcome of secondary acute promyelocytic leukemia (APL): A prospective analysis by the French-Belgian-Swiss APL group

Thorsten Braun , Sophie Cereja , Sylvie Chevret , Emmanuel Raffoux , Marie Beaumont et al.
Cancer, 2015, 121 (14), pp.2393-2399. ⟨10.1002/cncr.29389⟩
Journal articles hal-01237097v1

Efficacy and safety of the combination of rituximab, fludarabine, and mitoxantrone for rituximab-naive, recurrent/refractory follicular non-Hodgkin lymphoma with high tumor burden: a multicenter phase 2 trial by the Groupe d'Etude des Lymphomes de l'Adulte (GELA) and Groupe Ouest Est des Leucémies et Autres Maladies du Sang (GOELAMS).

Franck Morschhauser , Nicolas Mounier , Catherine Sebban , Pauline Brice , Phillippe Solal-Celigny et al.
Cancer, 2010, 116 (18), pp.4299-308. ⟨10.1002/cncr.25280⟩
Journal articles hal-00744246v1

Efficacy and safety of defibrotide in the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome following hematopoietic stem cell transplantation: Interim results from the defifrance study

Mohamad Mohty , Myriam Labopin , Delphine Lebon , Ana Berceanu , Charlotte Jubert et al.
Bone Marrow Transplantation, 2019, 54 (1), pp.231-232
Journal articles hal-03606394v1

Ibrutinib in very elderly patients with relapsed/refractory chronic lymphocytic leukemia: A real-world experience of 71 patients treated in France: A study from the French Innovative Leukemia Organization (FILO) group

Sophie Michallet , Arnaud Campidelli , Helene Lequeu , Marie-Sarah Dilhuydy , Olivier Tournilhac et al.
American Journal of Hematology, 2017, 92 (6), pp.E105 - E107. ⟨10.1002/ajh.24715⟩
Journal articles hal-01653723v1

Impact of HLA of Winning Cord Blood Unit on Outcomes after Double Umbilical Cord Blood Transplantation in Adults with Acute Leukemia: A Retrospective Study on Behalf of Eurocord, the Cord Blood Committee Cellular Therapy and Immunobiology Working Party and the Acute Leukemia Working Party of the EBMT

Federica Giannotti , Annalisa Ruggeri , Myriam Labopin , Jan Cornelissen , Mauricette Michallet et al.
Blood, 2015, 126 (23), pp.3111. ⟨10.1182/blood.V126.23.3111.3111⟩
Journal articles hal-01290435v1

Lenalidomide in combination with R-CHOP (R2-CHOP) as first-line treatment of patients with high tumour burden follicular lymphoma: a single-arm, open-label, phase 2 study

Hervé Tilly , Franck Morschhauser , Olivier Casasnovas , Thierry Jo Molina , Pierre Feugier et al.
The Lancet Haematology, 2018, 5 (9), pp.e403-e410. ⟨10.1016/S2352-3026(18)30131-5⟩
Journal articles hal-02329073v1

Evaluating abbreviated induction with fludarabine, cyclophosphamide, and dose-dense rituximab in elderly patients with chronic lymphocytic leukemia

Caroline Dartigeas , Eric van den Neste , Christian Berthou , Hervé Maisonneuve , Stéphane Leprêtre et al.
Leukemia & lymphoma, 2016, 57 (2), pp.328--334. ⟨10.3109/10428194.2015.1063139⟩
Journal articles hal-01272930v1

Rituximab maintenance versus observation following abbreviated induction with chemoimmunotherapy in elderly patients with previously untreated chronic lymphocytic leukaemia (CLL 2007 SA): an open-label, randomised phase 3 study

Caroline Dartigeas , Eric van den Neste , Julie Léger , Hervé Maisonneuve , Christian Berthou et al.
The Lancet Haematology, 2018, 5 (2), pp.e82 - e94. ⟨10.1016/S2352-3026(17)30235-1⟩
Journal articles hal-01712402v1

Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life-experience of the French network

Laurence Schenone , Caroline Houillier , Marie Laure Tanguy , Sylvain Choquet , Kossi Agbetiafa et al.
Bone Marrow Transplantation, 2022, 57 (6), pp.966-974. ⟨10.1038/s41409-022-01648-z⟩
Journal articles hal-03703797v1
Image document

Real-world use of defibrotide for veno-occlusive disease/sinusoidal obstruction syndrome: the DEFIFrance Registry Study

Mohamad Mohty , Didier Blaise , Régis Peffault de Latour , Myriam Labopin , Jean Henri Bourhis et al.
Bone Marrow Transplantation, 2022, ⟨10.1038/s41409-022-01900-6⟩
Journal articles hal-03915550v1
Image document

Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma.

Emmanuel Bachy , Roch Houot , Franck Morschhauser , Anne Sonet , Pauline Brice et al.
Haematologica, 2013, 98 (7), pp.1107-14. ⟨10.3324/haematol.2012.082412⟩
Journal articles hal-00933219v1
Image document

A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts

Sarah Huet , Bruno Tesson , Jean-Philippe Jais , Andrew Feldman , Laura Magnano et al.
Lancet Oncology, 2018, 19 (4), pp.549 - 561. ⟨10.1016/S1470-2045(18)30102-5⟩
Journal articles hal-01788996v1

Early matched sibling hematopoietic cell transplantation for adult AML in first remission using an age-adapted strategy: long-term results of a prospective GOELAMS study.

Bruno Lioure , Marie C Béné , Arnaud Pigneux , Anne Huynh , Patrice Chevallier et al.
Blood, 2012, 119 (12), pp.2943-8. ⟨10.1182/blood-2011-05-352989⟩
Journal articles hal-00849702v1
Image document

Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial

Mathilde Hunault-Berger , N. Maillard , C. Himberlin , C. Recher , Aline Schmidt-Tanguy et al.
Blood Cancer Journal, 2017, 7 (6), pp.e568. ⟨10.1038/bcj.2017.50⟩
Journal articles inserm-01814864v1

Sequential allogeneic hematopoietic stem cell transplantation for active refractory/relapsed myeloid malignancies: results of a reduced-intensity conditioning preceded by clofarabine and cytosine arabinoside, a retrospective study on behalf of the SFGM-TC

Amandine Le Bourgeois , Myriam Labopin , Ambroise Marçais , Regis Peffault de Latour , Didier Blaise et al.
Annals of Hematology, 2020, 99 (8), pp.1855-1862. ⟨10.1007/s00277-020-04074-7⟩
Journal articles hal-02977222v1

Study of thrombin generation with St Genesia to evaluate xaban pharmacodynamics: Analytical performances over 18 months

Geoffrey Foulon-Pinto , Georges Jourdi , Julien Perrin , Johan Abdoul , Guillaume Paris et al.
International Journal of Laboratory Hematology, 2021, 43 (4), pp.821-830. ⟨10.1111/ijlh.13443⟩
Journal articles hal-03102064v1

Induction-related cost of patients with acute myeloid leukaemia in France.

Virginie Nerich , Bruno Lioure , Maryline Rave , Christian Recher , Arnaud Pigneux et al.
Int J Clin Pharm, 2011, 33 (2), pp.191-9. ⟨10.1007/s11096-010-9462-1⟩
Journal articles istex hal-00849659v1
Image document

Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 study

Franck Morschhauser , Steven Le Gouill , Pierre Feugier , Sarah Bailly , Emmanuelle Nicolas-Virelizier et al.
The Lancet Haematology, 2019, 6 (8), pp.e429-e437. ⟨10.1016/S2352-3026(19)30089-4⟩
Journal articles hal-02586078v1